We are live on ! Find out more
PRTC

PureTech Health

Delisted

PRTC was delisted on the 20th of May, 2026.

6 hedge funds and large institutions have $1.88M invested in PureTech Health in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

1.05% less ownership

Funds ownership: 1.47%0.42% (-1.1%)

19% less capital invested

Capital invested by funds: $2.33M → $1.88M (-$451K)

25% less funds holding

Funds holding: 86 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

PRTC Hedge Fund Activity: Q3 2025 in Review

6 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q3 2025, worth a combined $1.88M — down 19% from $2.33M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PRTC and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Pentwater Capital Management, adding an estimated $439K. The largest seller was Portolan Capital Management, exiting entirely with an estimated $479K sold.

  • 6 institutional investors held PureTech Health (PRTC) as of Q3 2025, down from 8 in Q2 2025.
  • Funds reported $1.88M of PureTech Health stock for Q3 2025, down 19% quarter-over-quarter.
  • 1 fund opened new PureTech Health positions in Q3 2025 and 3 closed out, a net change of -2 holders.
  • The largest PureTech Health buyer in Q3 2025 was Pentwater Capital Management, an estimated $439K added.
  • The largest PureTech Health seller in Q3 2025 was Portolan Capital Management, an estimated $479K sold.

Based on aggregated 13F filings for Q3 2025.